Viragen Inc (fka VRAI)

[simpsonrc1]

glass- here's something should apply to vra:

http://www.investorshub.com/boards/read_msg.asp?message_id=1247658

Check (chart) out what SARS did for aegn this past may.

http://finance.lycos.com/home/stocks/charts.asp?symbols=NASDAQ:AEGN

In case you don't want to log on (it's free) here is the abstract:

Home The Journal Current Issue Original research
Volume 362, Number 9380 26 July 2003
Research letters
Treatment of SARS with human interferons
J Cinatl, B Morgenstern, G Bauer, P Chandra, H Rabenau, H W Doerr
Effective antiviral agents are needed to treat severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infection. We assessed the antiviral potential of recombinant interferons against two clinical isolates of SARS-CoV--FFM-1, from Frankfurt patients, and Hong Kong--replicated in Vero and Caco2 cells. Interferon ß was five to ten times more effective in Caco2 cells. Interferon effectively inhibited SARS-CoV replication, but with a selectivity index 50-90 times lower than that for interferon ß. Interferon was slightly better than interferon in Vero cell cultures, but was completely ineffective in Caco2 cell cultures. Interferon ß could be useful alone or in combination with other antiviral drugs for the treatment of SARS.

Lancet 2003; 362: 293-94